Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
about
αV integrins in angiogenesis and cancerEpigenetic regulation in human melanoma: past and futureThe heterochronic microRNA let-7 inhibits cell motility by regulating the genes in the actin cytoskeleton pathway in breast cancerComparative studies of vertebrate Beta integrin genes and proteins: ancient genes in vertebrate evolutionDicer1-mediated miRNA processing shapes the mRNA profile and function of murine platelets.MicroRNA-mediated control in the skinMiR-let-7a inhibits cell proliferation, migration, and invasion by down-regulating PKM2 in cervical cancer.Osteopetrosis with micro-lacunar resorption because of defective integrin organizationMicroRNA-26a inhibits the growth and invasiveness of malignant melanoma and directly targets on MITF gene.Regulation of cancer aggressive features in melanoma cells by microRNAs.microRNA and cancerEpigenetics of human cutaneous melanoma: setting the stage for new therapeutic strategiesMutagen-specific mutation signature determines global microRNA binding.Acrolein decreases endothelial cell migration and insulin sensitivity through induction of let-7aMicroRNA-7 inhibits epithelial-to-mesenchymal transition and metastasis of breast cancer cells via targeting FAK expressionThe role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanomaTranscriptome profiling identifies HMGA2 as a biomarker of melanoma progression and prognosis.MicroRNA in Melanoma.MicroRNAs Regulate Key Effector Pathways of SenescenceMicroRNAs in skin and wound healing.MicroRNA regulation of glycoprotein B5R in oncolytic vaccinia virus reduces viral pathogenicity without impairing its antitumor efficacyMYC protein inhibits transcription of the microRNA cluster MC-let-7a-1~let-7d via noncanonical E-box.Aberrant regulation of the LIN28A/LIN28B and let-7 loop in human malignant tumors and its effects on the hallmarks of cancerHigh let-7a microRNA levels in KRAS-mutated colorectal carcinomas may rescue anti-EGFR therapy effects in patients with chemotherapy-refractory metastatic disease.Argonaute Family Protein Expression in Normal Tissue and Cancer Entities.Epigenetic mechanisms in commonly occurring cancers.Melanoma MicroRNA signature predicts post-recurrence survival.CXCR4 downregulation of let-7a drives chemoresistance in acute myeloid leukemia.Targeting oncomiRNAs and mimicking tumor suppressor miRNAs: Νew trends in the development of miRNA therapeutic strategies in oncology (Review).Profiling and discovery of novel miRNAs from formalin-fixed, paraffin-embedded melanoma and nodal specimens.Alterations of MicroRNAs in Solid Cancers and Their Prognostic Value.Epigenetics and dermatological disease.Epigenetics in human melanoma.Role of miRNAs in the progression of malignant melanoma.Role of 3'-untranslated region translational control in cancer development, diagnostics and treatment.Plasma MicroRNA Levels Following Resection of Metastatic Melanoma.Stem cell microRNAs in senescence and immortalization: novel players in cancer therapy.Integrin-epigenetics: a system with imperative impact on cancer.MicroRNAs in the pathogenesis of malignant melanoma.Driving transcriptional regulators in melanoma metastasis.
P2860
Q26851768-297BBB2D-64B8-42BC-A46A-36510E70B915Q28085681-045563B6-C875-43FD-8825-82747EAAF20EQ28283868-E8BD6E06-FAA2-454B-9A4A-E4A5B7432B17Q28659439-BE835D9A-636F-4687-85CF-5561CB0B8220Q33429232-78557C32-EEB7-4B06-817C-4A2628DCFD1BQ33583478-FDA18DB8-E8EC-46D4-A126-15BADDF68FB1Q33709646-2D9B648D-342C-41CA-8614-53E375C61457Q33799330-38F3B8BF-F1A3-44D2-B667-2C947348A04CQ33886196-0C6D7AAD-3657-4B64-AD63-F847B0B9EB5CQ33889489-2B0B8155-B27B-4A64-8842-27E39348EDDAQ33954625-0CFB9DD0-5FB6-44C4-BE63-41A493CE89A1Q33980682-D013DD09-7BE1-4390-A803-1E668F87271FQ34077879-FC36A363-801A-4629-8578-1BD15CF5FD18Q34248329-0E1B310C-82C6-4F9F-8025-151851A6044EQ34372477-424CDF26-9BB3-4D4E-961F-1DED9D7AEE35Q34459058-34C7D1EE-D17C-4E3F-A341-6481DFA4DB1DQ34708265-3699DDD4-0DEB-44D1-BB2D-835B1983243BQ34986222-E26E1CAD-D655-40F6-973F-BBCD9D62E5BAQ35001155-3CE66A81-2900-48E7-A5FA-D9292554845FQ35033659-9A88C85C-5054-42C0-86E9-1CF7CF001F2AQ35086717-D854153E-5B3D-4CB4-BAD1-87981A45717DQ35562715-18E89D68-D66A-4622-8E4A-7F70C720A308Q35881362-A1EF5730-2C5F-4072-B426-E87FE1708107Q36051517-6F2606AF-E8E1-4A3D-8330-AEB678CE5E4AQ36102773-13613715-E1CA-46BD-9551-D45CFD7618A1Q36286662-89354228-3302-4C13-A377-6F46F299F796Q36327521-64E80972-CC20-4547-9FB6-D71C25C7171BQ36891005-D77A359C-6F9D-4D26-9949-2BE7A9C15982Q36992190-798DAE1A-BAD5-42EE-9412-6BC5FEAF0361Q37312978-C23890CC-A352-4FAE-95E9-F1699BBE22A3Q37328429-A9E142EC-E48E-4C4E-B45D-79DD1E640083Q37346201-486944C0-81B3-4F91-B91B-6B9FE8F4D6CFQ37531849-F556228F-400E-4DC7-92D5-2DD85E6ED2EBQ37565026-B9A77723-18CD-4CE2-AB1F-FE853EF7172CQ37617262-10A1D365-1CA0-4C6C-B84E-C340537BE238Q37693673-2DC77FC1-43F0-4B66-AFDC-287D7A47EC0FQ37906461-5BD82768-49C1-49CC-B952-BA0C1FB42F2EQ37967439-CD7F137A-FE7C-48C9-98BB-EB80ED955D48Q38012532-D82E327C-E5DF-435D-870B-57A2418A65C0Q38017594-5528A01D-FD09-4F64-AE01-72D16EE3A727
P2860
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
@en
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
@nl
type
label
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
@en
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
@nl
prefLabel
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
@en
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma.
@nl
P356
P1433
P1476
Integrin beta 3 expression is regulated by let-7a miRNA in malignant melanoma
@en
P2093
D W Müller
P2888
P304
P356
10.1038/ONC.2008.282
P407
P577
2008-08-04T00:00:00Z